石药集团开启的BD预告,风靡了整个医药圈,多家药企相继发布BD预告。6月11日,荣昌生物官微文章称,在第62届欧洲肾脏病学会年会(ERA)期间,现场多位跨国医药公司BD经理主动接洽,围绕泰它西普的国际合作、技术授权等商业拓展方向展开深度交流。泰它西普是荣昌生物目前两款商业化产品之一,针对自免领域。投资者对其BD期待已久,2024年公司管理层就表示,争取尽快完成年内泰它西普出海落地。正大制药也发布了...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.